Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Kyowa Hakko synthesizes phenylalanine esters intended for atopic dermatitis

Jan. 3, 2001

Pivotal trial of Ortec's donor site wound treatment shows promising results; PMA filing upcoming

Jan. 3, 2001

Chemokine receptor antagonists in GlaxoSmithKline portfolio

Jan. 2, 2001

Name change and recent TB4 research results announced by the former Alpha 1 Biomedicals

Jan. 2, 2001

Apthera for canker sores approved in Canada

Dec. 22, 2000

New 4-arylpiperidine derivatives for the treatment of pruritus

Dec. 21, 2000

New retinoid-like compounds described by Allergan

Dec. 19, 2000

Novartis seeks FDA approval for nonsteroidal eczema therapy

Dec. 19, 2000

Vitamin D-like effects discovered in novel Roche compounds

Dec. 18, 2000

New agent for atopic dermatitis is endowed with antihistaminic and antiinflammatory effects

Dec. 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...